Growth Metrics

BioLineRx (BLRX) Free Cash Flow Growth (1y) (2014 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 60.84%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 88.70%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -15.72%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 66.37%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 3.98%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 137.65%
10 BioLineRx 9.32 Bn 9.30 Bn 154,000.00 62.86%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 62.86%
Sep 30, 2025 78.56%
Jun 30, 2025 98.43%
Mar 31, 2025 81.59%
Dec 31, 2024 -272.08%
Sep 30, 2024 0.76%
Jun 30, 2024 -17.55%
Mar 31, 2024 -76.32%
Dec 31, 2023 189.00%
Sep 30, 2023 -14.19%
Jun 30, 2023 -53.96%
Mar 31, 2023 -43.39%
Dec 31, 2022 -3.40%
Sep 30, 2022 -72.85%
Jun 30, 2022 8.28%
Mar 31, 2022 10.34%
Dec 31, 2021 -0.15%
Sep 30, 2021 8.32%
Jun 30, 2021 -22.35%
Mar 31, 2021 7.84%
Dec 31, 2020 -0.30%
Sep 30, 2020 11.30%
Jun 30, 2020 13.36%
Mar 31, 2020 -46.77%
Dec 31, 2019 -7.39%
Sep 30, 2019 -2.61%
Jun 30, 2019 -3.41%
Mar 31, 2019 32.02%
Dec 31, 2018 17.24%
Sep 30, 2018 3.02%
Jun 30, 2018 -49.02%
Mar 31, 2018 -80.18%
Dec 31, 2017 -45.22%
Sep 30, 2017 -107.85%
Jun 30, 2017 -28.84%
Mar 31, 2017 7.39%
Dec 31, 2016 -41.27%
Sep 30, 2016 -0.91%
Jun 30, 2016 -44.42%
Mar 31, 2016 -21.93%
Dec 31, 2015 37.35%
Sep 30, 2015 6.96%
Jun 30, 2015 47.92%
Mar 31, 2015 0.75%
Dec 31, 2014 -28.61%
Sep 30, 2014 26.26%
Jun 30, 2014 30.60%
Mar 31, 2014 36.29%